129 related articles for article (PubMed ID: 28063735)
21. [A case of small-cell lung cancer associated with paraneoplastic limbic encephalitis during chemotherapy].
Isobe K; Nagata R; Ota H; Sugino K; Shibuya K; Homma S
Nihon Kokyuki Gakkai Zasshi; 2011 Aug; 49(8):602-6. PubMed ID: 21894777
[TBL] [Abstract][Full Text] [Related]
22. [A case of dermatomyositis becoming symptomatic after recurrence of small cell lung cancer].
Yoneshima Y; Hirano S; Morino E; Takeda Y; Sugiyama H; Kobayashi N; Kudo K
Nihon Kokyuki Gakkai Zasshi; 2010 Feb; 48(2):118-22. PubMed ID: 20184242
[TBL] [Abstract][Full Text] [Related]
23. Nephrotic syndrome as paraneoplastic manifestation of a primary pulmonary lymphoepithelioma-like carcinoma.
Arenas MD; Gil MT; Malek T; Farré J; Fernández Morejón FJ; Arriero JM; Aranda I; Moledous A; Alvarez-Ude F
Clin Nephrol; 2009 Sep; 72(3):206-10. PubMed ID: 19761726
[TBL] [Abstract][Full Text] [Related]
24. Foothold of NPHS2 mutations in primary nephrotic syndrome.
Jaffer AT; Ahmed WU; Raju DS; Jahan P
J Postgrad Med; 2011; 57(4):314-20. PubMed ID: 22120861
[TBL] [Abstract][Full Text] [Related]
25. Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2006; 57(1):17-21. PubMed ID: 16739878
[TBL] [Abstract][Full Text] [Related]
26. KANK deficiency leads to podocyte dysfunction and nephrotic syndrome.
Gee HY; Zhang F; Ashraf S; Kohl S; Sadowski CE; Vega-Warner V; Zhou W; Lovric S; Fang H; Nettleton M; Zhu JY; Hoefele J; Weber LT; Podracka L; Boor A; Fehrenbach H; Innis JW; Washburn J; Levy S; Lifton RP; Otto EA; Han Z; Hildebrandt F
J Clin Invest; 2015 Jun; 125(6):2375-84. PubMed ID: 25961457
[TBL] [Abstract][Full Text] [Related]
27. Nephrotic syndrome complicating adenocarcinoma of the lung with resolution after resection.
Coltharp WH; Lee SM; Miller RF; Averbuch MS
Ann Thorac Surg; 1991 Feb; 51(2):308-9. PubMed ID: 1989552
[TBL] [Abstract][Full Text] [Related]
28. The impact of steroids on the injured podocytes in nephrotic syndrome.
Hosseiniyan Khatibi SM; Ardalan M; Abediazar S; Zununi Vahed S
J Steroid Biochem Mol Biol; 2020 Feb; 196():105490. PubMed ID: 31586640
[TBL] [Abstract][Full Text] [Related]
29. [Molecular mechanisms in nephrotic syndrome: role of c-mip in podocyte dysfunctions].
Zhang SY; Audard V; Lang P; Sahali D
Med Sci (Paris); 2010; 26(6-7):592-6. PubMed ID: 20619160
[No Abstract] [Full Text] [Related]
30. The glomerular permeability factors in idiopathic nephrotic syndrome.
Davin JC
Pediatr Nephrol; 2016 Feb; 31(2):207-15. PubMed ID: 25925039
[TBL] [Abstract][Full Text] [Related]
31. The feasibility study of Carboplatin plus Etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias.
Minegishi Y; Kuribayashi H; Kitamura K; Mizutani H; Kosaihira S; Okano T; Seike M; Azuma A; Yoshimura A; Kudoh S; Gemma A
J Thorac Oncol; 2011 Apr; 6(4):801-7. PubMed ID: 21336181
[TBL] [Abstract][Full Text] [Related]
32. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.
Koshikawa M; Mukoyama M; Mori K; Suganami T; Sawai K; Yoshioka T; Nagae T; Yokoi H; Kawachi H; Shimizu F; Sugawara A; Nakao K
J Am Soc Nephrol; 2005 Sep; 16(9):2690-701. PubMed ID: 15987752
[TBL] [Abstract][Full Text] [Related]
33. The combination of Young's syndrome and small cell lung cancer-A spiky connection?
Forster M; Enting D; Nicholson AG; O'Brien M; Popat S
Lung Cancer; 2010 Mar; 67(3):372-5. PubMed ID: 19954857
[TBL] [Abstract][Full Text] [Related]
34. [Successful treatment of small cell lung cancer with secondary immune thrombocytopenic purpura].
Terashita S; Hirano K; Hirai T; Narabayashi T; Hara Y; Endo K; Hirabayashi M
Nihon Kokyuki Gakkai Zasshi; 2009 Nov; 47(11):1036-40. PubMed ID: 19994601
[TBL] [Abstract][Full Text] [Related]
35. Some unusual paraneoplastic syndromes. Case 4. Paraneoplastic nephrotic syndrome in a patient with lung cancer.
Ebert B; Shaffer K; Rennke H
J Clin Oncol; 2003 Jul; 21(13):2624-5. PubMed ID: 12829687
[No Abstract] [Full Text] [Related]
36. Paraneoplastic nephrotic syndrome in patients with lung cancer.
Ohara G; Satoh H; Kurishima K; Ohtsuka M; Hizawa N
Intern Med; 2009; 48(20):1817-20. PubMed ID: 19834274
[TBL] [Abstract][Full Text] [Related]
37. [Small cell lung cancer associated with paraneoplastic bullous pemphigoid].
Lakhdar N; El Khattabi W; Lahroussi M; Afif H; Aichane A
Rev Pneumol Clin; 2014 Jun; 70(3):169-72. PubMed ID: 24874405
[TBL] [Abstract][Full Text] [Related]
38. Dermatomyositis as the first manifestation of a lung tumor.
Castro AS; Barroso A; Parente B
Rev Port Pneumol; 2013; 19(4):179-83. PubMed ID: 23602006
[TBL] [Abstract][Full Text] [Related]
39. Small cell anaplastic carcinoma of the lung with mesangial proliferative glomerulonephritis.
Jermanovich NB; Giammarco R; Ginsberg SJ; Tinsley RW; Jones DB
Arch Intern Med; 1982 Feb; 142(2):397-9. PubMed ID: 6277262
[TBL] [Abstract][Full Text] [Related]
40. [Chronic intestinal pseudo-obstruction as a paraneoplastic presentation of limited-stage small cell lung cancer].
Mifune D; Tsukada H; Hosoi M; Okajima M; Yokoyama A
Nihon Kokyuki Gakkai Zasshi; 2010 Jun; 48(6):439-43. PubMed ID: 20608088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
